Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by
deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide …

Fabry disease is an X-linked inherited lysosomal disorder that causes accumulation of
glycosphingolipids in body fluids and tissues, leading to progressive organ damage and …

Fabry disease (FD) is an X‐linked lysosomal storage disorder caused by pathogenic
variants in the α‐galactosidase A (GLA) gene that leads to reduced or undetectable α …

Aims Cardiac amyloidosis is common in elderly patients with aortic stenosis (AS) referred for
transcatheter aortic valve implantation (TAVI). We hypothesized that patients with dual aortic …

Abstract The Society for Cardiovascular Magnetic Resonance (SCMR) last published its
comprehensive expert panel report of clinical indications for CMR in 2004. This new …

Enzyme replacement therapy (ERT) with recombinant α‐galactosidase A (r‐αGAL A) for the
treatment of Fabry disease has been available for over 15 years. Long‐term treatment may …

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations of the
GLA gene that result in a deficiency of the enzymatic activity of α-galactosidase A and …

Fabry disease is an X-linked lysosomal storage disorder caused by the accumulation of
glycosphingolipids in various tissues and body fluids, leading to progressive organ damage …

Anderson-Fabry disease (AFD) is a rare X-linked inherited metabolic disorder which results
in a deficiency or absence of the enzyme α-galactosidase A, leading to the accumulation of …

Anderson–Fabry disease (AFD) is a lysosomal storage disorder characterized by glycolipid
accumulation in cardiac cells, associated with a peculiar form of hypertrophic …